Childrens Hospital & Research Center Oakland announced today a $1 million gift from the Clorox Company to support research with an aim of developing a vaccine against meningococcal disease a potentially deadly bacterial infection that affects millions of children and young adults throughout the world.
The gift establishes The Clorox Endowed Chair for Immunobiology & Vaccine Development at Childrens Hospital Oakland Research Institute (CHORI), supporting the groundbreaking research of Dan Granoff, MD, a physician scientist who played a major role in the development and evaluation of vaccines against Haemophilus influenzae in children. Granoff is also the author or co-author of more than 175 peer-reviewed research articles in areas of microbiology and vaccine research.
"Clorox is thrilled to partner with Childrens in the fight against this devastating disease," says Donald R. Knauss, chairman and CEO of the Clorox Company. "Establishing this chair and the research it will foster aligns strategically with our companys global cause platform to safeguard family well-being with a focus on infection prevention."
Bertram Lubin, MD, president and CEO of Childrens Hospital & Research Center Oakland, agrees: "Our shared vision of a world free of meningococcal disease translates into potentially preventing disease in millions of children and young adults. Childrens is excited and humbled by this transformative and generous gift."
Meningococcal bacteria cause potentially deadly infections triggering meningitis and sepsis -- a serious whole-body inflammatory state that is especially virulent among infants and young adults -- in Africa, the United States, and Europe. Granoffs laboratory focuses on Group B strain and on vaccines for prevention of epidemics in Africa caused by other strains.
The Clorox Endowed Chair for Immunobiology & Vaccine Development at CHORI will allow Granoff to expand his vaccine research against meningococcal disease, and in the years ahead, recruit his replacement at the Research Institute.
"I am confident that a successful vaccine can be made to control meningococcal disease," says Granoff. "This generous gift from The Clorox Company brings us closer than ever to finding a means for eradicating this devastating bacterial infection."
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.
CenTrak Unveils Revolutionary BLE Multi-Mode Platform for Health Care RTLS Solutions
March 22nd 2024CenTrak, the industry leader in real-time location technology, introduces the groundbreaking BLE Multi-Mode Platform, setting a new standard for Real-Time Location Systems (RTLS) in health care. Discover how this innovative solution enhances location data precision and streamlines operations for health care organizations.